Advancing Care Coordination and Telehealth Deployment program to explore processes for bringing care into the home for the chronically ill
Amsterdam, the Netherlands – Royal Philips Electronics (NYSE: PHG, AEX: PHIA) and its consortium partners today announced the launch of the Advancing Care Coordination and Telehealth Deployment (ACT) program. The Philips-led ACT program is the first to explore the organizational and structural processes needed to successfully implement care coordination and telehealth (CC&TH) services on a large scale. This EU-funded program includes healthcare authorities, clinical experts, universities and industry partners. By monitoring CC&TH initiatives in five European regions, the program will create a “cookbook” of best practices to facilitate CC&TH deployment. This could potentially transform care for millions of chronically ill people and save healthcare systems billions of Euros each year.
Chronic illness is growing to pandemic proportions. In the EU, some 10 million people suffer from heart failure1, 20 million have chronic obstructive pulmonary disease2 (COPD) and 60 million live with diabetes3. Each year, these three conditions cost EU healthcare systems around EUR 125 billion. With CC&TH services, chronically ill people can be treated effectively in their own homes through remote management systems and integrated networks of caregivers. The ultimate goal of these services is to improve health and help patients help themselves by giving them more independence, freedom and control over their health and lifestyle. Clinical studies4-6 have shown these services can help reduce hospital admissions, days in hospital and mortality rates. However so far CC&TH has been mainly limited to pilot programs due to the difficulty of translating such research into practice.
“The ACT program is a key step towards the widespread use of care coordination and telehealth services. It takes research in this field to the next stage of implementation. The program examines how best to deploy and integrate telehealth to improve outcomes for patients and healthcare systems, and ensure they are cost effective,” said Professor Stanton Newman of Health Psychology, School of Health Sciences, City University London, UK and Principal Investigator on the Whole System Demonstrator, the largest telehealth trial conducted to date.
To do that, the ACT program brings together healthcare authorities, companies, universities and hospitals. Five partner European regions (the Basque Country and Catalonia in Spain, Groningen in the Netherlands, Lombardy in Italy and Scotland in the UK) will deploy and operate their own CC&TH schemes for heart failure, COPD and diabetes patients. The systems will be monitored over a 24-month period to identify “best in class” processes, structures and ways of working. Data and experiences will be shared between regions, allowing promising candidates to be further optimized. The resulting optimized structures and behaviors will be published, allowing other healthcare authorities to develop their own CC&TH systems.
“Philips aims to transform healthcare through meaningful, patient-centric innovation,” said Bas Verhoef, President Market Group EMEA, Philips Healthcare. “People increasingly want healthcare on their own terms, in ways that let them get on with their normal lives. Moving care from the hospital to the home makes that possible while also helping healthcare systems cope with the increased pressures due to aging populations and the growth of chronic disease”.
“It is an essential evolution, but making it happen requires cooperation from across the healthcare value chain,” continues Verhoef. “The ACT program shows there is a strong willingness to cooperate across Europe, and Philips is proud to lead such a strong consortium that is united in wanting to improve care and quality of life for millions.”
Uniting leading European healthcare experts from a number of domains, the ACT program is part of the European Innovation Partnership on Active and Healthy Ageing (EIP-AHA). The EIP-AHA is an initiative from the European Commission under its Innovation Union strategy, and aims to increase the average healthy lifespan by two years by 2020.
For more information, visit: http://www.act-program.eu.
 Braunschweig F, Cowie MR, Auricchio A. What are the costs of heart failure? Europace. 2011;13:ii13–ii17
 Inglis SC, Cark RA, McAlister FA, et al. Structured telephone support or telemonitoring programmes for patients with chronic heart failure. Cochrane Database Syst Rev. 2010;8:CD007228
 Inglis SC, Clark RA, McAlister FA, Stewart S, Cleland JG. Which components of heart failure programmes are effective? A systematic review and meta-analysis of the outcomes of structured telephone support or telemonitoring as the primary component of chronic heart failure management in 8323 patients: Abridged Cochrane Review. Eur J Heart Fail 2011. Sep;13(9):1028-1040.
 BMJ 2012; 344 doi: http://dx.doi.org/10.1136/bmj.e3874
For further information, please contact:
Sabine van Deursen
Philips Healthcare Communications
Tel: +43 664 3916 832
The ACT consortium members include:
- Philips Healthcare
- Aristotle University of
- Telbios, Italy
- Philips Electronics
Nederland B.V., The Netherlands
- UMC Groningen, The
- Asociacion Centro De
Excelencia Internacional En Investigacion Sobre Cronicidad, Spain
- Consorci Institut
d'Investigacions Biomèdiques August Pi i Sunyer, Spain
- Agencia D’informació, Avaluació I Qualitat En Salut, Spain
- Servicio Vasco de
- NHS 24, Scotland, United
- University of Hull, United
- City University London,
- Guy’s & St Thomas’ NHS
Foundation Trust, United Kingdom
- And affiliate members:
Foundation Zorg Binnen Bereik (Care within reach), Amersfoort, The Netherlands; Center of Technology in Medicine and Health (CTMH), Sweden; Basque healthcare technology provider (OSATEK ), Spain; Galicia Region (SERGAS), Spain; Saxonia Region, Germany.
For more information, visit: http://www.act-program.eu
About Royal Philips Electronics
Royal Philips Electronics (NYSE: PHG, AEX: PHIA) er et selskap innen helse og velvære som fokuserer på å forbedre menneskers liv gjennom relevante innovasjoner innen områdene helse, livsstil og lys. Hovedkontoret ligger i Nederland, og Philips hadde i 2012 en omsetning på 24,8 milliarder Euro og 118 000 ansatte i over 100 land. Selskapet er markedsledende innen hjerte- og akuttbehandling og omsorg i hjemmet, energieffektive lysløsninger og nye lyssystemer. Philips er dessuten ledende innen barbering og grooming for menn, bærbar underholdning og tannhelseprodukter. Nyheter fra Philips finnes her: www.philips.com/newscenter.